吞嚥障礙管理市場－全球產業規模、佔有率、趨勢、機會、預測：按產品、適應症、分銷管道、地區和競爭格局分類，2021-2031年

全球吞嚥困難管理市場預計將從 2025 年的 42.8 億美元成長到 2031 年的 61.3 億美元，複合年成長率為 6.17%。

此領域涵蓋旨在診斷、治療和支持吞嚥困難患者的醫療產品和服務，主要產品包括營養增稠劑、改善食物質地的食品、餵食管和必要的診斷設備。市場成長的主要促進因素是全球人口老化以及中風和帕金森氏症等神經系統疾病發病率的上升。根據美國言語語言聽力協會 (ASHA) 預測，到 2024 年，美國將有約 1,510 萬成年人患有吞嚥困難，這凸顯了對相關護理的巨大需求。

然而，由於專業營養管理和長期照護的高成本，市場面臨許多障礙。不同醫療體系報銷政策的不一致，常常限制了人們獲得必需營養補充劑和治療輔助器具的機會。這些經濟限制阻礙了成本敏感地區採用高品質的解決方案，從而有效地限制了該行業在全球範圍內的發展和普及。

市場促進因素

全球人口快速老化是吞嚥困難管理市場的主要促進因素。隨著老齡化，肌肉無力、唾液分泌減少等生理機能下降會顯著損害吞嚥功能，需要臨床介入。這種人口結構變化推動了對改善食物質地食品和旨在預防吸入性肺炎等併發症的診斷篩檢的需求。根據日本內務部於2024年9月發布的《2024年日本統計手冊》，65歲及以上人口將達到3625萬，這將成為專業營養解決方案的主要目標群體，並為護理產品提供穩定的需求基礎。

同時，神經系統疾病的增加也推動了市場發展。例如，中風和巴金森氏症常常會損害控制吞嚥的神經通路，需要即時進行管飼或使用增稠劑等干涉措施。根據世界卒中組織發布的《2024年全球卒中概況》（2024年1月發布），全球每年新增中風病例超過1220萬例，需要康復治療的患者人數持續成長。此外，根據美國癌症協會統計，解剖惡性腫瘤發生率的上升，包括預計2024年美國新增58,450例口腔癌和咽癌病例，凸顯了對先進治療輔助手段的需求。

市場挑戰

與專業營養管理和長期照護相關的高昂費用，以及不一致的保險報銷政策，是限制全球吞嚥困難管理市場發展的主要障礙。營養增稠劑、改良食品和腸內營養管等必需產品通常需要持續投入大量資金，而這些費用往往無法完全由醫療保險所涵蓋。在患者必須自費的地區，高品質管理方案的採用率顯著降低。這種經濟負擔迫使醫療服務提供者和患者家庭選擇療效較差但成本較低的替代方案，這直接阻礙了收入成長和先進吞嚥困難產品的市場滲透。

聯邦政府削減臨床服務經費進一步加劇了這種經濟壓力。據美國言語語言聽力協會 (ASHA) 稱，2024 年最終確定的聯邦醫療保險 (Medicare) 醫生報銷方案將轉換係數降低了約 3.4%，實際上降低了言語語言治療服務的報銷率。此類報銷削減迫使醫療機構節約營運預算，限制了其投資先進診斷設備和全面長期營養治療的能力。因此，市場環境趨於僵化，迫使醫療服務提供者優先考慮財務永續性，而非實施專業的管理解決方案。

市場趨勢

3D列印質地可控食品的出現正在改變市場格局，滿足了人們對美味安全營養攝取的需求。與傳統的食物泥食物不同，3D列印技術能夠客製化食物結構，使其模擬日常膳食，同時保持安全吞嚥所需的精確質地。這項創新提高了患者的治療依從性，並使其能夠在醫療機構中實現工業化應用。根據3DPrint.com網站2024年4月刊報道，“胃腸病學開始為吞嚥困難患者工業化生產3D列印食品”，胃腸病學公司已開始為醫療機構工業化生產這些特殊產品，日產量達700公斤。這種向自動化且外觀精美的營養輸送方式的轉變，標誌著與傳統家庭自製混合餐食的重大變革。

同時，穿戴式生物回饋療法和神經刺激設備的研發正推動治療重點從被動管理轉向主動復健。這些技術能夠恢復神經性吞嚥困難患者的神經控制功能，提供根治性治療而非暫時性補償。這一趨勢的驅動力在於對吞嚥困難根本原因的設備進行了大量投資。根據《亞太生物製藥》（BioPharma APAC）2024年3月刊報道，“Phagenesis完成4200萬美元D輪資金籌措，助力吞嚥困難治療創新”，Phagenesis已完成4200萬美元資金籌措。這些進展表明，人們越來越關注能夠改善長期復原效果的介入性技術。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球吞嚥障礙治療市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 依產品類型（藥品、腸內營養管、營養補充品）
  • 適應症（口腔和咽部吞嚥困難、食道吞嚥困難）
  • 分銷通路（醫院藥局、零售藥局、藥局、專科診所）
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美吞嚥障礙管理市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲吞嚥障礙治療市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區吞嚥障礙管理市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲吞嚥障礙治療市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美洲吞嚥障礙治療市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球吞嚥障礙管理市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Eisai Co. Ltd
• Becton, Dickinson, and Company
• Hormel Health Labs
• AstraZeneca Plc
• Cipla Ltd
• Nestle Health Science
• Kent Precision Food Group Inc.
• Bracco Diagnostics Inc.
• Phagenesis Ltd
• Cook medical Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Dysphagia Management Market is projected to expand from USD 4.28 Billion in 2025 to USD 6.13 Billion by 2031, registering a CAGR of 6.17%. This sector encompasses medical products and services designed to diagnose, treat, and support individuals experiencing swallowing difficulties, with key offerings including nutritional thickeners, texture-modified foods, feeding tubes, and essential diagnostic equipment. Market growth is largely driven by the aging global population and the increasing incidence of neurological disorders such as stroke and Parkinson's disease. According to the American Speech-Language-Hearing Association, approximately 15.10 million adults in the United States were affected by dysphagia in 2024, highlighting the critical demand for care.

However, the market faces significant hurdles due to the high costs associated with specialized nutrition and long-term management. Inconsistent reimbursement policies across various healthcare systems frequently restrict access to essential feeding devices and therapeutic aids. These financial constraints often hinder the adoption of premium solutions in cost-sensitive regions, effectively limiting the broader development and penetration of the global industry.

Market Driver

The rapidly aging global population acts as a primary catalyst for the dysphagia management market. As individuals age, physiological declines such as muscle weakness and reduced saliva production significantly impair swallowing functions, necessitating clinical intervention. This demographic shift fuels demand for texture-modified foods and diagnostic screenings to prevent complications like aspiration pneumonia. According to the 'Statistical Handbook of Japan 2024' released by the Ministry of Internal Affairs and Communications in September 2024, the population aged 65 and over reached 36.25 million, representing a substantial target demographic for specialized nutritional solutions and ensuring a steady baseline of demand for long-term care products.

Simultaneously, the rising prevalence of neurological disorders propels market momentum. Conditions such as stroke and Parkinson's disease often disrupt the neural pathways controlling deglutition, requiring immediate interventions via feeding tubes and thickening agents. The World Stroke Organization's 'Global Stroke Fact Sheet 2024' noted in January 2024 that over 12.2 million new strokes occur annually worldwide, creating a continuous influx of patients requiring rehabilitation. Additionally, the increasing incidence of anatomical malignancies, such as the estimated 58,450 new cases of oral cavity and pharyngeal cancer in the United States in 2024 per the American Cancer Society, underscores the necessity for advanced therapeutic aids.

Market Challenge

The high expense associated with specialized nutrition and prolonged care, coupled with inconsistent reimbursement policies, serves as a primary obstacle restricting the Global Dysphagia Management Market. Essential products such as nutritional thickeners, modified texture foods, and feeding tubes often carry significant ongoing costs that are not fully covered by healthcare insurance schemes. In regions where patients must bear these expenses out-of-pocket, the adoption of premium management solutions is markedly lower. This financial burden forces healthcare providers and families to opt for less effective, lower-cost alternatives, thereby directly stalling revenue growth and the broader penetration of advanced dysphagia products.

This economic pressure is further intensified by reductions in federal funding for clinical services. According to the American Speech-Language-Hearing Association, in 2024, the Medicare Physician Fee Schedule finalized a conversion factor reduction of approximately 3.4%, which effectively lowered the reimbursement rates for speech-language pathology services. Such cuts in compensation compel medical facilities to restrict their operational budgets, limiting their ability to invest in sophisticated diagnostic equipment or comprehensive long-term nutritional therapies. Consequently, the market faces stunted expansion as providers prioritize financial viability over the procurement of specialized management solutions.

Market Trends

The emergence of 3D-printed texture-modified foods is transforming the market by addressing the need for palatable, safe nutrition. Unlike traditional pureed meals, 3D printing allows for customized food structures that mimic regular meals while maintaining the precise consistency required for safe swallowing. This innovation improves patient compliance and enables industrial scalability for healthcare institutions. According to 3DPrint.com, April 2024, in the article 'Gastronology Launches Industrial Production of 3D Printed Food for Dysphagia Patients', Gastronology commenced industrial production of these specialized products with a daily capacity of 700 kilograms to serve healthcare facilities. This shift toward automated, visually appealing nutrition represents a significant departure from conventional home-blended diets.

Simultaneously, the development of wearable biofeedback and neurostimulation devices is shifting focus from passive management to active rehabilitation. These technologies restore neural control in patients with neurogenic dysphagia, offering curative therapies rather than temporary compensation. This trend is driven by substantial investment in devices targeting the underlying causes of swallowing disorders. According to BioPharma APAC, March 2024, in the article 'Phagenesis Secures $42M in Series D Funding to Revolutionize Swallowing Dysfunction Treatment', Phagenesis closed a $42 million investment round to accelerate the commercialization of its Phagenyx neurostimulation system. Such advancements highlight a growing focus on interventional technologies that improve long-term recovery outcomes.

Key Market Players

• Eisai Co. Ltd
• Becton, Dickinson, and Company
• Hormel Health Labs
• AstraZeneca Plc
• Cipla Ltd
• Nestle Health Science
• Kent Precision Food Group Inc.
• Bracco Diagnostics Inc.
• Phagenesis Ltd
• Cook medical Inc.

Report Scope

In this report, the Global Dysphagia Management Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dysphagia Management Market, By Product

• Drug
• Feeding Tubes
• Nutritional solutions

Dysphagia Management Market, By Indication

• Oropharangeal Dysphagia
• Esophageal Dysphagia

Dysphagia Management Market, By Distribution Channel

• Hospital pharmacies
• Retail pharmacies
• Drug store
• Specialty clinics

Dysphagia Management Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dysphagia Management Market.

Available Customizations:

Global Dysphagia Management Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Dysphagia Management Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Drug, Feeding Tubes, Nutritional solutions)
  • 5.2.2. By Indication (Oropharangeal Dysphagia, Esophageal Dysphagia)
  • 5.2.3. By Distribution Channel (Hospital pharmacies, Retail pharmacies, Drug store, Specialty clinics)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Dysphagia Management Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Indication
  • 6.2.3. By Distribution Channel
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Dysphagia Management Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Indication
      • 6.3.1.2.3. By Distribution Channel
  • 6.3.2. Canada Dysphagia Management Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Indication
      • 6.3.2.2.3. By Distribution Channel
  • 6.3.3. Mexico Dysphagia Management Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Indication
      • 6.3.3.2.3. By Distribution Channel

7. Europe Dysphagia Management Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Indication
  • 7.2.3. By Distribution Channel
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Dysphagia Management Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Indication
      • 7.3.1.2.3. By Distribution Channel
  • 7.3.2. France Dysphagia Management Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Indication
      • 7.3.2.2.3. By Distribution Channel
  • 7.3.3. United Kingdom Dysphagia Management Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Indication
      • 7.3.3.2.3. By Distribution Channel
  • 7.3.4. Italy Dysphagia Management Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Indication
      • 7.3.4.2.3. By Distribution Channel
  • 7.3.5. Spain Dysphagia Management Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Indication
      • 7.3.5.2.3. By Distribution Channel

8. Asia Pacific Dysphagia Management Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Indication
  • 8.2.3. By Distribution Channel
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Dysphagia Management Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Indication
      • 8.3.1.2.3. By Distribution Channel
  • 8.3.2. India Dysphagia Management Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Indication
      • 8.3.2.2.3. By Distribution Channel
  • 8.3.3. Japan Dysphagia Management Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Indication
      • 8.3.3.2.3. By Distribution Channel
  • 8.3.4. South Korea Dysphagia Management Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Indication
      • 8.3.4.2.3. By Distribution Channel
  • 8.3.5. Australia Dysphagia Management Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Indication
      • 8.3.5.2.3. By Distribution Channel

9. Middle East & Africa Dysphagia Management Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Indication
  • 9.2.3. By Distribution Channel
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Dysphagia Management Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Indication
      • 9.3.1.2.3. By Distribution Channel
  • 9.3.2. UAE Dysphagia Management Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Indication
      • 9.3.2.2.3. By Distribution Channel
  • 9.3.3. South Africa Dysphagia Management Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Indication
      • 9.3.3.2.3. By Distribution Channel

10. South America Dysphagia Management Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Indication
  • 10.2.3. By Distribution Channel
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Dysphagia Management Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Indication
      • 10.3.1.2.3. By Distribution Channel
  • 10.3.2. Colombia Dysphagia Management Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Indication
      • 10.3.2.2.3. By Distribution Channel
  • 10.3.3. Argentina Dysphagia Management Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Indication
      • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Dysphagia Management Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Eisai Co. Ltd
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Becton, Dickinson, and Company
• 15.3. Hormel Health Labs
• 15.4. AstraZeneca Plc
• 15.5. Cipla Ltd
• 15.6. Nestle Health Science
• 15.7. Kent Precision Food Group Inc.
• 15.8. Bracco Diagnostics Inc.
• 15.9. Phagenesis Ltd
• 15.10. Cook medical Inc.

16. Strategic Recommendations

17. About Us & Disclaimer